Price alert —
Sign in to get a one-time email the moment AZN crosses your price. Free accounts included.
Sign in / create a free accountAstraZeneca PLC is a healthcare company listed in the US.
AZN last traded at $168.90, down 0.2% on the day; that's in the lower part of its 52-week range ($164.45–$212.71). Right now it's dipped below its recent average — a spot where watchers often look for signs the dip is stabilizing.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
On the latest daily bar, momentum sits mid-range (RSI 39), the trend is quiet (ADX 21), and trading is light at 0.7× normal volume. On the business side, revenue is growing 12% year over year and the business keeps about 11 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
Our cash-flow model pegs fair value near $97.97 (fair range $85–$138); today's price sits 72% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ Positive retained earnings
- ✓ Gross margin 82% (pricing power)
- ⚠ Debt exceeds cash
- ⚠ Quick ratio 0.59 (fragile)
- ⚠ Receivables growing faster than revenue
- ⚠ Inventory growing faster than revenue
Price implies ~21% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
AZN is a $262.8 billion company, priced at 25× last year's earnings, and the stock is trading near the bottom of its 52-week range.